Overview

* Ecolab ( ECL ) Q3 sales rose 4%, beating analyst expectations

* Growth driven by Institutional & Specialty, Life Sciences segments

Outlook

* Ecolab ( ECL ) expects 2025 adjusted EPS between $7.48 and $7.58, up 12% to 14%

* Company anticipates Q4 2025 adjusted EPS of $2.02 to $2.12, up 12% to 17%

* Ecolab ( ECL ) expects special charges of $0.34 per share in 2025, mainly for restructuring

Result Drivers

* PRICING AND VOLUME GROWTH - Ecolab's ( ECL ) Q3 results were driven by accelerating pricing from 2% to 3% and 1% volume growth, leading to strong EPS growth

* SEGMENT PERFORMANCE - Institutional & Specialty, Pest Elimination, and Life Sciences segments led growth, with Global Water's Food & Beverage and Global High-Tech sectors offsetting declines in Basic Industries and Paper

* OPERATING INCOME MARGIN - Ecolab's ( ECL ) organic operating income margin expanded to 18.7%, supported by sales growth and productivity improvements, despite growth-oriented investments

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Beat $4.17 $4.12

bln bln (17

Analysts

)

Q3 Meet $2.07 $2.07

Adjusted (21

EPS Analysts

)

Q3 EPS $2.05

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 14 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the specialty chemicals peer group is "buy"

* Wall Street's median 12-month price target for Ecolab Inc ( ECL ) is $294.00, about 4.9% above its October 27 closing price of $279.71

* The stock recently traded at 33 times the next 12-month earnings vs. a P/E of 34 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)